We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGNI icon
7526
PUT
Magnite
MGNI
$2.76B
$40K ﹤0.01%
+21,500
New +$53.7K
URG
7527
Ur-Energy
URG
$485M
$40K ﹤0.01%
58,517
+5,441
+10% +$3.31K
CSCI
7528
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$40K ﹤0.01%
168
-13
-7% -$2.71K
BETS
7529
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
CFMS
7530
DELISTED
Conformis, Inc. Common Stock
CFMS
$40K ﹤0.01%
664
-3,895
-85% -$311K
ZN
7531
PUT
DELISTED
Zion Oil & Gas, Inc.
ZN
$40K ﹤0.01%
18,600
+5,200
+39% +$12.7K
EPE
7532
PUT
DELISTED
EP Energy Corporation
EPE
$40K ﹤0.01%
16,900
+1,300
+8% +$3.11K
CASC
7533
DELISTED
Cascadian Therapeutics, Inc.
CASC
$40K ﹤0.01%
10,792
-5,334
-33% -$21.8K
CHNR icon
7534
China Natural Resources
CHNR
$4.55M
$39K ﹤0.01%
+364
New +$35.1K
GNSS icon
7535
Genasys
GNSS
$76.1M
$39K ﹤0.01%
+15,659
New +$33.5K
OTIV
7536
DELISTED
OTI On Track Innovations Ltd
OTIV
$39K ﹤0.01%
+28,366
New +$36.9K
CATX icon
7537
Perspective Therapeutics
CATX
$332M
$38K ﹤0.01%
9,427
+6,437
+215% +$30K
CBAT icon
7538
CBAK Energy Technology Ltd
CBAT
$44.3M
$38K ﹤0.01%
25,034
-2,231
-8% -$3.83K
FOCL
7539
EDAP TMS S.A.
FOCL
$229M
$38K ﹤0.01%
+13,294
New +$39.6K
EMX
7540
DELISTED
EMX Royalty
EMX
$38K ﹤0.01%
46,023
+27,959
+155% +$21.8K
FCEL icon
7541
FuelCell Energy
FCEL
$1.73B
$38K ﹤0.01%
+62
New +$43K
OESX icon
7542
Orion Energy Systems
OESX
$41M
$38K ﹤0.01%
+4,277
New +$39.3K
IRD
7543
Opus Genetics
IRD
$306M
$38K ﹤0.01%
+390
New +$39.6K
SUNE
7544
SUNation Energy
SUNE
$8.95M
0
UQM
7545
DELISTED
UQM Technologies, Inc.
UQM
$38K ﹤0.01%
+27,244
New +$34.8K
STLY
7546
DELISTED
Stanley Furniture Co Inc
STLY
$38K ﹤0.01%
43,130
+26,886
+166% +$26.7K
EMMS
7547
DELISTED
Emmis Communications Corp
EMMS
$38K ﹤0.01%
+11,433
New +$37.9K
BDSI
7548
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$38K ﹤0.01%
12,900
+2,700
+26% +$7.46K
OREX
7549
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
$38K ﹤0.01%
29,500
+17,200
+140% +$28K
CVM icon
7550
CEL-SCI Corp
CVM
$20.3M
$37K ﹤0.01%
+652
New +$35.1K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.